
Pancreatic organoids on a chip platform
An organoid on chip platform mimics robustly key features of human pancreas development. This is a stepping stone towards reliable diagnostic solutions for early-stage pancreatic cancer.
An organoid on chip platform mimics robustly key features of human pancreas development. This is a stepping stone towards reliable diagnostic solutions for early-stage pancreatic cancer.
Clinicians are using patient-specific tumor 'organoid' models as a preclinical companion platform to better evaluate immunotherapy treatment for appendiceal cancer.
Researchers have found a way to enhance radiation therapy using novel iodine nanoparticles.
The MasSpec Pen has shown to accurately identify tissues and surgical margins directly in patients and differentiate healthy and cancerous tissue from banked pancreas samples.
Researchers suggest using microneedles for immunotherapy due to the high abundance of immune cells under the skin. The aim is to vaccinate or treat different diseases with minimal invasiveness.
Researchers have used 3D bioprinting technology to create custom-shaped cartilage. They aim to make it easier for surgeons to safely restore the features of skin cancer patients living with nasal cartilage defects after surgery.
Researchers have experimentally demonstrated a novel cancer diagnosis technique based on the scattering of circularly polarized light.
To reduce tissue injury side effects from radiation therapy, researchers have developed 3D-printed gastrointestinal radioprotective devices that can be generated from patient CT scans.
Modern medicine needs better quality samples than traditional biopsy needles can provide, ultrasonically oscillating needles can improve treatment and reduce discomfort.
Scientists have designed a portable 3D imaging device which will improve the treatment and diagnosis of cancer.
Using AI and mobile digital microscopy, researchers hope to create screening tools that can detect precursors to cervical cancer in women in resource-limited settings.
Using a special dye, cells are colored according to their pH, and a machine learning algorithm can detect changes in the color spectrum due to cancer.
Researchers have developed a new tissue-section analysis system for diagnosing breast cancer based on artificial intelligence.
A machine learning algorithm helps accurately differentiate benign and premalignant colorectal polyps on CT colonography scans.
AI is helping researchers decipher images from a new holographic microscopy technique needed to investigate a key process in cancer immunotherapy “live” as it takes place.
Researchers have successfully designed and tested a system for rapid testing of large numbers of potential immunotherapy drugs.
Research has shown how microbubbles carrying powerful cancer drugs can be guided to the site of a tumour using antibodies.
Researchers are developing solutions designed to enable the analysis of breath gas to assist with the diagnosis of disease.
A dual-organ system enables the measurement of cardiac toxicity arising from breast cancer chemotherapy.
Researchers have developed an robotic system to enhance the safety and efficacy of endoscopic submucosal dissection (ESD) for the treatment of gastrointestinal cancer.
The new 3D hydrogels provide high rates of cell proliferation, as they mimic lymph nodes, where T-cells reproduce in vivo.
Scientists have paired 3D-printed, living human brain vasculature with advanced computational flow simulations to better understand tumor cell attachment to blood vessels.
Robotic surgery for patients with early stage, oropharyngeal squamous cell cancer is associated with improved health outcomes, including better long-term survival.
Researchers report innovative use of machine learning to help understand the interplay of genetic and other breast cancer risk factors.
Myriad Genetics, Inc. announced a new collaboration with OptraHEALTH to implement a cognitive chatbot named Gene to provide genetic and financial assistance information to prospective patients.
Researchers have developed a machine learning model that can predict chemotherapy-associated nephrotoxicity.
Nanoengineers plan to develop an immunotherapy for ovarian cancer using 3D-bioprinted plant virus nanoparticles.
Scientists at Purdue University have developed a skin patch that can deliver chemotherapy into melanoma tumors in an effective and painless way.
Improving the prediction of survival indicators in patients with breast cancer using tools from artificial intelligence and probabilistic modelling is the aim of ModGraProDep.